Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · Real-Time Price · USD
0.519
+0.029 (5.90%)
At close: Nov 4, 2024, 4:00 PM
0.510
-0.010 (-1.83%)
After-hours: Nov 4, 2024, 5:50 PM EST
Sensei Biotherapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for SNSE stock have an average target of 4.33, with a low estimate of 4.00 and a high estimate of 5.00. The average target predicts an increase of 734.30% from the current stock price of 0.52.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 7, 2024.
Analyst Ratings
The average analyst rating for SNSE stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +670.71% | Aug 7, 2024 |
Citigroup | Citigroup | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +670.71% | Jun 3, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +670.71% | May 24, 2024 |
Stephens & Co. | Stephens & Co. | Buy Reiterates $5 | Buy | Reiterates | $5 | +863.39% | May 24, 2024 |
Stephens & Co. | Stephens & Co. | Buy Initiates $5 | Buy | Initiates | $5 | +863.39% | May 14, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.14
from -1.22
EPS Next Year
-1.14
from -1.14
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | n/a | n/a | ||
Avg | n/a | n/a | n/a | ||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -1.07 | -0.97 | -0.49 | ||
Avg | -1.14 | -1.14 | -0.94 | ||
Low | -1.18 | -1.27 | -1.12 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.